Trial no.:
|
PACTR201711002719245 |
Date of Approval:
|
23/10/2017 |
Trial Status:
|
Registered in accordance with WHO and ICMJE standards |
|
TRIAL DESCRIPTION |
Public title
|
compairing stellate ganglion block with thoracic paravertebral block in acute upper limb ischemia |
Official scientific title |
Ultrasound guided T2 & T3 paravertebral block versus ultrasound guided stellate block in acute upper limb ischemia. |
Brief summary describing the background
and objectives of the trial
|
Unintentional intra-arterial injection of medication, either iatrogenic or self-administered, is a source of considerable morbidityachieve . Delivery of certain medications via arterial access has led to clinically important sequelae, including paresthesias, severe pain, motor dysfunction, compartment syndrome, gangrene, and limb loss..(stellate gangalion block Stellate ganglion block is possible method to produce sustained arterial and venous vasodilation, with many complications up to cardiac arrest ,t2 t3 thoracaic paravertebral block result in sympathectomy prevent upper ischemic limb from amputation |
Type of trial |
RCT |
Acronym (If the trial has an acronym then please provide) |
|
Disease(s) or condition(s) being studied |
upper limb ischemia ,stelate ganglion block ,t2 t3 thoracic para vertebral block , |
Sub-Disease(s) or condition(s) being studied |
|
Purpose of the trial |
Treatment: Other |
Anticipated trial start date |
26/10/2017 |
Actual trial start date |
29/10/2017 |
Anticipated date of last follow up |
26/12/2017 |
Actual Last follow-up date |
19/10/2017 |
Anticipated target sample size (number of participants) |
43 |
Actual target sample size (number of participants) |
40 |
Recruitment status |
Not yet recruiting |
Publication URL |
|
|